Incidence and prevalence of venous thromboembolism in Norway 2010 –2017
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), represents a major cause of mortality and morbidity, and is associated with reduced survival, substantial healthcare costs, and high recurrence rates [1]. It is the third-leading cardiovascular disorder, after myocardial infarction and stroke with approximately 10 million global cases diagnosed annually [2].
Source: Thrombosis Research - Category: Hematology Authors: Waleed Ghanima, Ellen Brodin, Anna Schultze, Leah Shepherd, Dimitra Lambrelli, Maria Ulvestad, Sreeram Ramagopalan, Sigrun Halvorsen Tags: Letter to the Editors-in-Chief Source Type: research
More News: Cardiology | Cardiovascular | Healthcare Costs | Heart | Heart Attack | Hematology | Norway Health | Pulmonary Thromboembolism | Stroke | Thrombosis